21st November, 2010 - Posted by health news - No Comments
Each time a pharmaceutical production facility is subjected to an review or inspection, the subject of FDA compliance is very likely to be one of the most pressing issues that will need to be addressed. Pharmaceutical consultants are progressively more being demanded to provide advice and help on what will be predicted from a production facility from an FDA compliance point of view through the course of an auditing assessment. Continue reading Read More
3rd November, 2010 - Posted by health news - No Comments
Small farms across the United States have begun to express concern about impending FDA regulations. In order to establish a clearer indication of what the new FDA compliance rules mean for them, many small farm operators are likely to seek the expertise of FDA consulting companies. Continue reading Read More
10th October, 2010 - Posted by health news - No Comments
At one point, prescribed drugs were all branded by the major pharmaceutical corporations. As a result, the companies were making enormous profits but we were having to pay extremely substantial rates for our treatment because corporations had a monopoly which allowed them to charge what they wanted. Now on the other hand many of these big branded prescriptions have come off patent and are internationally produced by a number of manufacturers. This means that rates have to be competitively priced in order to get any sales at all. This has had two beneficial impacts; we can now get the treatment we need at a more cost effective price and the pharmaceutical industry has evolved and developed as a result of the generic drugs. Pharmaceutical consulting is made use of by all of the corporations to guarantee that the condition of generic drugs is as high as branded medications and the opposite way round. Continue reading Read More
6th October, 2010 - Posted by health news - No Comments
In an effort to reduce the number of dangerous medicines which enter America the Food and Drug Administration is developing its border control policy. Predictive Risk-based Evaluation for Dynamic Import Compliance Targeting or PREDICT is a way to control the drugs which enter at the border. At the border the barcodes on the medicines will be scanned and this will be linked to a central database. If the manufacturer does not have the correct licenses to sell their products in the US then the central database will be able to alert the border deputies of this fact. The medicines will not be allowed into the US if FDA compliance has not been reached. Continue reading Read More
20th September, 2010 - Posted by health news - No Comments
A minimal amount of guidance really can go a long way as far as the developing of medical devices and supplements is concerned – and pharmaceutical consultancy companies make it their business to be entirely up to date with all the newest goings on in the market, including FDA compliance regulations and matters of Good Manufacturing Practice (GMP). Continue reading Read More